Actovegin Equals to Performance Enhancing Drug Doping: Fact or Fiction?
Actovegin is a biological drug that has been used for the treatment of sports muscle injuries. Several in vitro studies have shed light on potential mechanisms of action and the drug has consistently demonstrated its potential to reduce return from injury time for muscle tears in elite athletes. Yet it was banned for a time under the International Olympic Committee (IOC) as a blood doping agent, this ban was based on presumptuous conclusions and subsequently lifted after no indisputable evidence could be provided. This editorial aims to provide readers with some of the key, objective facts relating to Actovegin and then based on this, will offer an infromed opinion on its role in sports medicine. We also hope to highlight the importance of evidence-based medicine, particularly in the volatile field of Sports Medicine, and the need for facts, not fiction
History
Published in
Journal of Tissue Science & EngineeringPublisher
HilarisVersion
- VoR (Version of Record)
Citation
: Lee PYF, Kwan AP, Smith PM, Brock J, Nokes L (2016) 'Actovegin Equals to Performance Enhancing Drug Doping: Fact or Fiction?', Journal of Tissue Science Engineering 7: 179. doi:10.4172/2157-7552.1000179Electronic ISSN
2157-7552Cardiff Met Affiliation
- Cardiff School of Sport and Health Sciences
Cardiff Met Authors
Paul M. SmithCardiff Met Research Centre/Group
- High Performance
Copyright Holder
- © The Authors
Language
- en